Connection

Mark Lewis to Antiviral Agents

This is a "connection" page, showing publications Mark Lewis has written about Antiviral Agents.
Connection Strength

0.040
  1. SARS-CoV-2 variant prediction and antiviral drug design are enabled by RBD in vitro evolution. Nat Microbiol. 2021 09; 6(9):1188-1198.
    View in: PubMed
    Score: 0.022
  2. TLR7 agonists induce transient viremia and reduce the viral reservoir in SIV-infected rhesus macaques on antiretroviral therapy. Sci Transl Med. 2018 05 02; 10(439).
    View in: PubMed
    Score: 0.018
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.